mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.08 |
mRNA |
Crizotinib |
FIMM |
pan-cancer |
AAC |
0.3 |
0.08 |
mRNA |
BRD-K14844214 |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.09 |
mRNA |
VX-11e |
GDSC1000 |
pan-cancer |
AAC |
-0.056 |
0.09 |
mRNA |
PD-0332991 |
GDSC1000 |
pan-cancer |
AAC |
0.058 |
0.09 |
mRNA |
BRD-K99006945 |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.09 |
mRNA |
GDC-0941 |
gCSI |
pan-cancer |
AAC |
-0.1 |
0.09 |
mRNA |
BRD-K04800985 |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.09 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.09 |
mRNA |
rigosertib |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.09 |